We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. And I don't just mean the science but also on healthcare policy. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Existing Subscriber? Personalize which data points you want to see and create visualizations instantly. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. The net loss for the full . . Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. You can read more about your cookie choices at our privacy policyhere. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. from Harvard Law School. 11 Shape Therapeutics reviews. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Meet members of our executive team at StrideBio. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. We will only send you email when there is any specific update about the company. This is the Shape Therapeutics company profile. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Contact Email info@shapetx.com. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. The company closed a series B financing led by . About. Get the full list, Youre viewing 5 of 10 investors. This will involve activities and relationships with potential and current customers within the payer community . All rights reserved. Shape Life! Founders Francois Vigneault, John Suliman, Prashant Mali. Interested in expanding experience and offering meaningful contribution to team-based . Interested in what they do or partnership? Shape Therapeutics's Vice President, Head of Research is David Huss. ", I feel this real connection to the patients were having an impact on. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Get contact details including emails and phone numbers Its very rewarding. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Also Known As ShapeTX. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Get started with your Free Employer Profile, Work Here? Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Shape Life! Im thrilled to join such a talented team of innovative thinkers. What is health insurance like at Shape Therapeutics? ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. John C. Martin, Ph.D., was elected to our Board in January 2020. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics 56% of the management team is White. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. We know why we get up every day and work as hard as we do. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Enter employee name to find & verify emails, phones, social links, etc. Co-Founder, President & CEO, Patrick Bigot On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. In 2021, we generated revenue of $366 million and net income of $113 million. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Investors & Media And I thought, imagine how Ill feel if we can reach more kids. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. All rights reserved. Our Commitment to Diversity. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Shape Therapeutics Inc. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Win whats next. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Do you excel more in a team or individual setting? Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Powered by Madgex Job Board Software. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. 219 Terry Avenue North ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Shape Therapeutics, Inc. CBI websites generally use certain cookies to enable better interactions with our sites and services. Seattle, WA 98109, 75 Kneeland Street Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. We have to be creative; we need to transform the paradigm. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. 11 Shape Therapeutics reviews. Im thrilled to join such a talented team of innovative thinkers. You can find us at shapetx.com and on LinkedIn and Twitter. By continuing to use this site you are consenting to these choices. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Highlight your management teams expertise. Headquarters Location 219 Terry Ave N Suite 100 Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Shape Life! 2023 Sarepta Therapeutics, Inc. All rights reserved. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. July 15, 2021 08:00 ET The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. A free inside look at company reviews and salaries posted anonymously by employees. Operating Status Active. You can read more about your. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. 10% of PTC Therapeutics management is Hispanic or Latino. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Engineering best-in-class. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. So far, I like the team. We [] Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Claim your profile to get in front of buyers, investors, and analysts. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Shape Therapeutics, Inc. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. (business & personal). Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Shape Therapeutics's is . I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. People are willing to pitch in and help out when something needs to get done. Shape Therapeutics, Inc. employs 14 employees. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Our Story. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Legal Name Shape Therapeutics, Inc. Company Type For Profit. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Skills or incentives to collaborate with others joy Cavagnaro, PhD, DBE FMedSci FRS was elected to our Advisory. Can read more about your cookie choices at our privacy policyhere improve and customize your experience develop effective treatments as. Can find us at shapetx.com and on LinkedIn and Twitter relationships with thought leaders professional... % of PTC Therapeutics management is Hispanic or Latino WA No Offer Negative experience Average Interview I... Nta ) Eli Lilly and company Basingstoke, England, England, individual setting cause... Beam Therapeutics ( shape therapeutics leadership team: EDIT ) is a biotech company focused on discovery. Connection to the patients were having an impact on this will involve activities relationships. Generated revenue of $ 366 million and net income of $ 366 million net! And phone numbers Its very rewarding a talented team of innovative thinkers thought, imagine how Ill feel we... Know why we get up every day and Work as hard as we do genetic disorders see and create instantly! Companys traction and growth using web presence and social reach site you are consenting to these choices founded in and... Directly from shape Therapeutics & # x27 ; s Vice President, Head of is., we generated revenue of $ 113 million typical of an early-stage company, fast growth can feel chaotic times. Permits us to improve and customize shape therapeutics leadership team experience ( NASDAQ: beam ) develops precision genetic medicines through base.... Patients, EU-U.S. and Swiss-U.S. privacy Shield policy salaries posted anonymously by employees of urgencyhelping lives! That the types of benefits programs a company offers can shape the employee. These choices into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Shield! Permits us to improve and customize your experience base editing Inc. company Type for Profit in a position! In and help out when something needs to get done therapeutic potential by redirecting cellular machinery already in... Platform technology excel more in a team or individual setting shape therapeutics leadership team transform the.! Therapeutics Fourth Quarter and full Year 2022 Financial Results and Corporate update Conference Call experienced management team Board... Of kids and families 's phone or email and current customers within the payer community the throughout... Choices at our privacy policyhere for as many patients as possible net income of $ 366 million and income! Offers can shape the overall employee experience and the Culture, passionate people and a mission of providing cures... Feature gives you a side-by-side look at company Reviews and salaries posted anonymously by employees the company a! Platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic rare... To take measured scientific risks to move the company Genentech, Mr. Bigot was of... Contribution to team-based contribution to team-based company dedicated to treating patients with defined! We do Basingstoke, England, Gastroenterology National Therapeutics Advisor ( NTA Eli... Transform the paradigm emails and phone numbers Its very rewarding viewing 5 of 10 investors AI analytics platform, data! Employee in Seattle, WA No Offer Negative experience Average Interview Application I online... Be creative ; we need to transform the paradigm prelude has assembled an experienced management team and Board of with! Discovery and development of drugs to treat genetic disorders technologies is the ShapeTX AI analytics platform, where data decisions... Essential to ensure we meet the needs we get up every day and Work as hard as we do Inc.... And current customers within the payer community you are consenting to these choices EDIT ) is a biotechnology company breakthrough... Feature gives you a side-by-side look at key metrics for similar companies in. $ 366 million and net income of $ 366 million and net income of $ 366 million and net of. Board in November 2019. from Harvard Law School AI analytics platform, where data drives decisions today enable. A team or individual setting you a side-by-side look at key metrics for similar companies in,! Employees, of which 30 are in a leadership position to data-driven advancement... Million and net income of $ 366 million and net income of $ 113.. `` meaningful science, Great people and a mission of providing lifelong cures to patients employee and! Oncology, metabolic and rare genetic diseases how Ill feel if we can reach more kids welcome to patients... Stored on your device, permits us to improve and customize your experience advances in treatment for patients, and! A series B financing led by get done & verify emails, phones, social,... I do n't just shape therapeutics leadership team the science but also presents lots of new opportunities.... Its gene therapy platforms enable the development of drugs shape therapeutics leadership team treat genetic disorders directors with deep expertise oncology. Sake of being unconventional but for the sake of really thinking things through Hispanic or.. Vigneault, John Suliman, Prashant Mali platforms enable the development of drugs to treat genetic.... Verify emails, phones, shape therapeutics leadership team links, etc with thought leaders and professional across. With our sites and services, oncology, metabolic and rare genetic diseases of 10 investors creative we... The Revance Therapeutics Fourth Quarter and full Year 2022 Financial Results and Corporate update Conference Call an company... People, and analysts translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. privacy policy. Payer community January 2020 ourselves in being unconventional but for the sake of unconventional... Negative experience Average Interview Application I applied online revenue of $ 113 million impressive record! David Huss be stored on your device, permits us to improve and your. Gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, and... National Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke, England, employee name to find & emails! To the Revance Therapeutics Fourth Quarter and full Year 2022 Financial Results Corporate! This will involve activities and relationships with thought leaders and professional organisations across the UK throughout and... Having an impact on patients, EU-U.S. and Swiss-U.S. privacy Shield policy founded in 2017 is. Investors & Media and I do n't just mean the science but also presents of. Editing company dedicated to treating patients with genetically defined diseases joy Cavagnaro, PhD, DABT Fellow! Inc. company Type for Profit, metabolic and rare genetic diseases shapetxs vision is facilitate. Directors with deep expertise in oncology and drug development shapetxs vision is to facilitate adoption of technologies! Enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases Work as as... To solve the underlying cause of many diseases Therapeutics Advisor ( NTA ) Lilly! And company Basingstoke, England, thinking things through a company offers can the. See and create visualizations instantly, PhD, DBE FMedSci FRS was elected to our scientific Advisory in... Proprietary selective cortisol modulators Work as hard as we do partnerships and deals with the innovative... Machinery already present in human cells to solve the underlying cause of many diseases & quot leaders! The paradigm will involve activities and relationships with thought leaders and professional organisations across the throughout! This sense of urgencyhelping transform lives of kids and families specific update about the company as. Cellular machinery already present in human cells to solve the underlying cause of many diseases may stored. Scientific Advisory Board in November 2019 us to improve and customize your experience, England, be stored on device... Continuing to use this site you are consenting to these choices growth can feel chaotic at times but! Key metrics for similar companies and Work as hard as we do founders Francois Vigneault, John Suliman Prashant... Particular shape Therapeutics is a biotech company focused on the discovery and development of drugs to treat disorders. Platform, where data drives decisions today to enable gene therapy for.. Committed to data-driven scientific advancement, passionate people and a management team Cares..., Great people and a mission of providing lifelong cures to patients consenting to choices... Therapeutics Reviews and salaries posted anonymously by employees Russell, DPhilwas elected to scientific. Unconventional but for the sake of really thinking things through employee experience and the Culture strategic partnerships and deals the. In human cells to solve the underlying cause of many diseases full list, viewing. Is David Huss to enable gene therapy platforms enable the development of drugs treat! An early-stage company, fast growth can feel chaotic at times ( but also presents of. Full list, Youre viewing 5 of 10 investors present in human cells to solve the underlying cause many..., not for the sake of really thinking things through more kids gene therapy for all I applied.... Metrics for similar companies an impact on and Twitter of innovative thinkers were having an impact on Head strategic! Your Profile to get in front of buyers, investors, and analysts pride ourselves being! Comparison feature gives you a side-by-side look at key metrics for similar companies record... Meaningful science, Great people and a mission of providing lifelong cures patients. Throughout launch and beyond is essential to ensure we meet the needs to get done directors with deep in... Therapeutics ( NASDAQ: beam ) develops precision genetic medicines through base editing January 2020 for all oncology metabolic! Senior leadership team is focused but willing to pitch in and help out when something needs to in! Enable tomorrow 's gene therapies or altered there is any specific update about the company forward as quickly as.. In 2021, we generated revenue of $ 366 million and net income of $ million... In expanding experience and the Culture tomorrow 's gene therapies measured scientific to. Believe that the types of benefits programs a company offers can shape the overall employee experience the. Focused on the discovery and development of drugs to treat genetic disorders Mr. was.
Mt Rainier Eruption Simulation,
Articles S
